About Ambey Laboratories Limited bond.

This comprehensive profile covers key factual information about Ambey Laboratories Limited. Incorporated in 1985, Ambey Laboratories manufactures agrochemical products for crop protection. EPS in Mar-2024 was 4.13. Current ratio in Mar-2024 was 1.56. Debt/Equity in Mar-2024 was 1.03. Debt/EBITDA in Mar-2024 was 3.14. Interest coverage ratio in Mar-2024 was 3.24. Operating Cashflow to total debt in Mar-2024 was -0.40. Total revenue for Mar-2025(E) was ₹107.59. Net income for Mar-2025(E) stood at ₹11.78. Total assets as of Mar-2024 were ₹79.40. Operating cash flow for Mar-2024 was ₹-12.94. Peers and comparison entities consist of Ambey Laboratories Limited, Gujarat Fluorochemicals Limited, Navin Fluorine International Limited, Vinati Organics Limited. As of Sep 2024, promoters hold 69.90% while others hold N/A% of equity. Key strengths include: Company has a good return on equity (ROE) track record: 3 Years ROE 33.6%; ; . Key risks include: Though the company is reporting repeated profits, it is not paying out dividend; Debtor days have increased from 35.3 to 56.6 days.; Working capital days have increased from 46.1 days to 89.5 days. Leadership team details include Abdul Quadir (independent Non-Executive Director), Rimple Sarin (Company Secretary & Compliance Officer), Rishita Gupta (Non Executive Director), Roni Soni (independent Non-Executive Director), Sandeep Bansal (Non Executive Director), Sarina Gupta (Whole Time Director), Sarvar Aalam (Chief Financial Officer). This detailed corporate overview is structured to provide a thorough understanding of all available data points, enhance search visibility, and support investor analysis.